TrialEuropean journal of clinical pharmacology2016

Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma.

Song Mu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.